Cargando…

Clinical Pharmacokinetics of a Lipid-Based Formulation of Risperidone, VAL401: Analysis of a Single Dose in an Open-Label Trial of Late-Stage Cancer Patients

BACKGROUND AND OBJECTIVES: A clinical trial was conducted to measure and analyse the pharmacokinetic parameters of a lipid formulation of risperidone, VAL401. The VAL401 formulation is designed to repurpose risperidone from an antipsychotic to an adenocarcinoma treatment, with the lipid formulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dilly, Suzanne J., Morris, George S., Taylor, Paul C., Parmentier, Frederic, Williams, Coralie, Afshar, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616216/ https://www.ncbi.nlm.nih.gov/pubmed/30628010 http://dx.doi.org/10.1007/s13318-018-00538-4

Ejemplares similares

An Open-label Trial of Risperidone and Fluoxetine in Children with Autistic Disorder
por: Desousa, Avinash
Publicado: (2010)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
por: Walling, David P, et al.
Publicado: (2021)

Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of Risperidone 2 mg: An Open-Label, Single-Dose, Fasting, Randomized-Sequence, Two-Way Crossover Study in Healthy Male Chinese Volunteers
por: Liu, Yun, et al.
Publicado: (2012)

Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone
por: Perlstein, Itay, et al.
Publicado: (2022)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]
Publicado: (2022)

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan, Vishal, et al.
Publicado: (2011)

Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
por: Galloway, Gantt P, et al.
Publicado: (2005)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
por: Pandina, Gahan, et al.
Publicado: (2012)

Audits of 401(k) Plans
por: Group, Deloitte & Touche
Publicado: (2018)

Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation
por: Çelik, Burak
Publicado: (2017)

Stability Indicating HPLC Determination of Risperidone in Bulk Drug and Pharmaceutical Formulations
por: Dedania, Zarna R., et al.
Publicado: (2011)

Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
por: Ganguli, Rohan, et al.
Publicado: (2008)

Effects of Risperidone on Core Symptoms of Autistic Disorder Based on Childhood Autism Rating Scale: An Open Label Study
por: Ghaeli, Padideh, et al.
Publicado: (2014)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
por: Mattingly, Greg W., et al.
Publicado: (2020)

Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film
por: Chen, Fang, et al.
Publicado: (2020)

Selection of 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained‐Release Prototype Formulations and Standard Acetaminophen Formulation: An Open‐Label, Randomized, Proof‐of‐Principle Pharmacokinetic Study
por: Yue, Yong, et al.
Publicado: (2017)

Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin’s lymphoma: an open-label, multicenter, dose-escalation phase 1 study
por: Goto, Hideki, et al.
Publicado: (2022)

Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

CompTIA security+ SY0-401
por: Barrett, Diane, et al.
Publicado: (2015)

Memorandum: request for continuation of experiment R401
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1974)

Forcecom Developer Certification Handbook (DEV401)
por: Kabe, Siddhesh
Publicado: (2012)

Complete idiot's guide to 401 (k) plans
por: Bogosian, Wayne G, et al.
Publicado: (2002)

Pre-retirement use of 401(k) funds
por: Bernstein, David
Publicado: (2021)

Childhood Hydrocephalus in Sokoto: Experience with 401 Series
por: Obanife, Henry Olayere, et al.
Publicado: (2021)

Vals : para piano, Op.69 No.2
por: Chopin, Frédéric, 1810-1849
Publicado: (1958)

Vals : para piano, Op.70 No.2
por: Chopin, Frédéric, 1810-1849
Publicado: (1959)

External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data
por: Karatza, Eleni, et al.
Publicado: (2022)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
por: Soria-Chacartegui, Paula, et al.
Publicado: (2021)

The Laser Fiducial Line measurement precision in open air media determined in comparison with laser tracker AT-401
por: Batusov, V, et al.
Publicado: (2015)

An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors
por: Komatsu, Yoshito, et al.
Publicado: (2022)

Comparative cardiovascular safety of risperidone and olanzapine, based on electrocardiographic parameters and blood pressure: A prospective open label observational study
por: Choure, Balwant Kisanrao, et al.
Publicado: (2014)

Two cases of life‐threatening arrhythmia induced by risperidone: evaluation of risperidone and 9‐hydroxy‐risperidone concentrations
por: Ito, Asami, et al.
Publicado: (2017)

A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
por: Chan, Stephen L., et al.
Publicado: (2022)

CompTIA security+ (exam SY0-401)
por: Dunkerley, Dawn, et al.
Publicado: (2014)

Colección teatro-vol. 401 al vol. 658
Publicado: (1964)

MED22/401: Hypertext Atlas For Pathology Education
por: Feit, J, et al.
Publicado: (1999)

40.1 INFLAMMATORY CYTOKINES ARE ELEVATED IN THE MIDBRAIN IN SCHIZOPHRENIA
por: Purves-Tyson, Tertia, et al.
Publicado: (2018)

Pharmacokinetic aspects and in vitro–in vivo correlation potential for lipid-based formulations
por: Kollipara, Sivacharan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e7nslflcuhc39o4kfrdounpbkf